Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2012

01-06-2012 | Research Article

Management of hypertension and factors affecting its control in Jordanian renal transplant recipients

Authors: Nailya Bulatova, Al-Motassem Yousef, Hisham Qusa, Ghada Al Khayat, Wadad Ailabouni, Ayman Wahbeh, Muhammad Al-Ulemat

Published in: International Journal of Clinical Pharmacy | Issue 3/2012

Login to get access

Abstract

Background Hypertension affects 70–90 % of all kidney transplant recipients. It is associated with poor graft survival and is a contributing factor to the increased cardiovascular mortality. The reasons for the insufficient blood pressure control in transplanted patients have not been thoroughly investigated. Objective To evaluate the extent of blood pressure control in Jordanian hypertensive renal transplant recipients and to assess factors associated with such control. Setting Three outpatient renal transplant clinics in Amman. Method A cross-sectional observational study including 181 patients. We have considered blood pressure <130/80 mm Hg as controlled hypertension. Bivariate and multivariate logistic regression analyses were used to determine clinical factors associated with achievement of blood pressure control. Main outcome measures Proportion of patients who achieved hypertension control and clinical factors associated with good blood pressure control. Results Mean systolic blood pressure was 128.6 ± 16.3 mm Hg and mean diastolic blood pressure was 82.8 ± 11.5 mm Hg. Blood pressure control was achieved only in 58 % of patients. The most commonly prescribed antihypertensives were calcium channel blockers (58 %) followed by beta-blockers (44 %). In bivariate analysis, female gender (p = 0.017) and creatinine clearance (p = 0.002) were positively associated, while number of antihypertensive medications was inversely associated (p = 0.04) with achievement of blood pressure control. After including these factors in multivariate logistic regression analysis, only creatinine clearance remained independently associated with hypertension control (odds ratio, OR 1.04; 95 % confidence interval [CI] 1.01–1.06; p = 0.003). Conclusion Blood pressure control among renal transplant recipients in Jordan was found to be inadequate. The only factor found to be independently associated with adequate blood pressure control was creatinine clearance.
Literature
1.
go back to reference Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States 1988 to 1996. N Engl J Med. 2000;342:605–12.PubMedCrossRef Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States 1988 to 1996. N Engl J Med. 2000;342:605–12.PubMedCrossRef
2.
go back to reference Premasathian NC, Muehrer R, Brazy PC, Becker BN. Blood pressure control in kidney transplantation: therapeutic implications. J Hum Hypertens. 2004;18:871–7.PubMedCrossRef Premasathian NC, Muehrer R, Brazy PC, Becker BN. Blood pressure control in kidney transplantation: therapeutic implications. J Hum Hypertens. 2004;18:871–7.PubMedCrossRef
3.
go back to reference Wadei HM, Textor SC. Hypertension in the kidney transplant recipient. Transplant Rev (Orlando). 2010;24(3):105–20.CrossRef Wadei HM, Textor SC. Hypertension in the kidney transplant recipient. Transplant Rev (Orlando). 2010;24(3):105–20.CrossRef
4.
go back to reference Tylicki L, Habicht A, Watshinger B, Horl W. Treatment of hypertension in renal transplant recipients. Curr Opin Urol. 2003;13:91–8.PubMedCrossRef Tylicki L, Habicht A, Watshinger B, Horl W. Treatment of hypertension in renal transplant recipients. Curr Opin Urol. 2003;13:91–8.PubMedCrossRef
5.
go back to reference Tutone VK, Mark PB, Stewart GA, Tan CC, Roger RSC, Geddes CC, et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant. 2005;19:181–92.PubMedCrossRef Tutone VK, Mark PB, Stewart GA, Tan CC, Roger RSC, Geddes CC, et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant. 2005;19:181–92.PubMedCrossRef
6.
go back to reference Opelz G, Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5:2725–31.PubMedCrossRef Opelz G, Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5:2725–31.PubMedCrossRef
7.
go back to reference Midtvedt K, Neumayer HH (2000) Management strategies for posttransplant hypertension. Transplantation 70(Suppl 11):SS64–SS69. Midtvedt K, Neumayer HH (2000) Management strategies for posttransplant hypertension. Transplantation 70(Suppl 11):SS64–SS69.
8.
go back to reference Büscher R, Vester U, Wingen AM, Hoyer PF. Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatr Nephrol. 2004;19:1202–11.PubMedCrossRef Büscher R, Vester U, Wingen AM, Hoyer PF. Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatr Nephrol. 2004;19:1202–11.PubMedCrossRef
9.
go back to reference Bulatova N, Yousef AM, Al-Khayyat G, Qosa H. Adverse effects of tacrolimus in renal transplant patients from living donors. Curr Drug Saf. 2011;6(1):3–11.PubMedCrossRef Bulatova N, Yousef AM, Al-Khayyat G, Qosa H. Adverse effects of tacrolimus in renal transplant patients from living donors. Curr Drug Saf. 2011;6(1):3–11.PubMedCrossRef
10.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.PubMedCrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.PubMedCrossRef
11.
go back to reference Mailloux LU, Levey AS. Hypertension in patients with chronic renal disease. Am J Kidney Dis. 1998;32(Suppl 3):S120–41.PubMedCrossRef Mailloux LU, Levey AS. Hypertension in patients with chronic renal disease. Am J Kidney Dis. 1998;32(Suppl 3):S120–41.PubMedCrossRef
12.
go back to reference EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. Nephrol Dial Transplant. 2002;17(suppl 4):1–67. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. Nephrol Dial Transplant. 2002;17(suppl 4):1–67.
13.
go back to reference National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 suppl 1):S1–290. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 suppl 1):S1–290.
14.
go back to reference Treatment of adults and children with renal failure: standards and audit measures (ed 3). London, UK, Royal College of Physicians of London and the Renal Association, 2002. ISBN 1 86016 105 7. Treatment of adults and children with renal failure: standards and audit measures (ed 3). London, UK, Royal College of Physicians of London and the Renal Association, 2002. ISBN 1 86016 105 7.
15.
go back to reference Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77(4):299–311.PubMedCrossRef Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77(4):299–311.PubMedCrossRef
16.
go back to reference Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, et al. Hypertension after kidney transplantation. Am J Kidney Dis. 2004;43:1071–81.PubMedCrossRef Kasiske BL, Anjum S, Shah R, Skogen J, Kandaswamy C, Danielson B, et al. Hypertension after kidney transplantation. Am J Kidney Dis. 2004;43:1071–81.PubMedCrossRef
17.
go back to reference Modena FM, Hostetter TH, Salahudeen AK, Najarian JS, Matas AJ, Rosenberg ME. Progression of kidney disease in chronic renal transplant rejection. Transplantation. 1991;52(2):239–44.PubMedCrossRef Modena FM, Hostetter TH, Salahudeen AK, Najarian JS, Matas AJ, Rosenberg ME. Progression of kidney disease in chronic renal transplant rejection. Transplantation. 1991;52(2):239–44.PubMedCrossRef
Metadata
Title
Management of hypertension and factors affecting its control in Jordanian renal transplant recipients
Authors
Nailya Bulatova
Al-Motassem Yousef
Hisham Qusa
Ghada Al Khayat
Wadad Ailabouni
Ayman Wahbeh
Muhammad Al-Ulemat
Publication date
01-06-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9626-2

Other articles of this Issue 3/2012

International Journal of Clinical Pharmacy 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine